{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:34:00Z","timestamp":1791182040290,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/mph.0b013e318279e392","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T08:11:12Z","timestamp":1358496672000},"page":"315-320","source":"Crossref","is-referenced-by-count":15,"title":["Mast Cell Sarcoma in an Infant"],"prefix":"10.1097","volume":"35","author":[{"given":"Marnelli A.","family":"Bautista-Quach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie L.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Kheradpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Zuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H.","family":"Rowsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-15-20210227","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal.","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"R3-15-20210227","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp.2006.040857","article-title":"Mast-cell sarcoma of the tibia.","volume":"60","author":"Brcic","year":"2007","journal-title":"J Clin Pathol"},{"key":"R4-15-20210227","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00000478-200307000-00019","article-title":"Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma.","volume":"27","author":"Chott","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R5-15-20210227","first-page":"739","article-title":"Mast cell sarcoma with tissue eosinophilia arising in the ascending colon.","volume":"12","author":"Kojima","year":"1999","journal-title":"Mod Pathol"},{"key":"R6-15-20210227","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12185-011-0952-2","article-title":"Successful treatment of mast cell sarcoma of the uterus with imatinib.","volume":"94","author":"Ma","year":"2011","journal-title":"Intl J Hematol"},{"key":"R7-15-20210227","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jcp.39.6.596","article-title":"Mast cell sarcoma of the larynx.","volume":"39","author":"Horny","year":"1986","journal-title":"J Clin Pathol"},{"key":"R8-15-20210227","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/jclinpath-2011-200154","article-title":"Mast cell sarcoma of the small intestine: a case report.","volume":"64","author":"Bugalia","year":"2011","journal-title":"J Clin Pathol"},{"key":"R9-15-20210227","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00062752-200401000-00009","article-title":"Clinical, genetic, and therapeutic insights into systemic mast cell disease.","volume":"11","author":"Tefferi","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"R10-15-20210227","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1182\/blood-2007-02-076471","article-title":"The tyrosine kinase FES is an essential effector of KITD816V proliferation signal.","volume":"110","author":"Voisset","year":"2007","journal-title":"Blood"},{"key":"R13-15-20210227","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib.","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"R14-15-20210227","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2011.01598.x","article-title":"A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.","volume":"86","author":"Mital","year":"2011","journal-title":"Eur J Haematol"},{"key":"R15-15-20210227","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/leu.2011.354","article-title":"Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor beta chain and KIT V654A.","volume":"26","author":"Spector","year":"2011","journal-title":"Leukemia"},{"key":"R17-15-20210227","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00000478-200005000-00009","article-title":"Paraffin section immunophenotype of cutaneous and extracutaneous mast cell disease: comparison to other hematopoietic neoplasms.","volume":"24","author":"Yang","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R18-15-20210227","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.pas.0000138181.89743.7b","article-title":"CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.","volume":"28","author":"Sotlar","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R19-15-20210227","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/hupa.2001.24319","article-title":"Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117Kit, and bcl-x(L).","volume":"32","author":"Jordan","year":"2001","journal-title":"Hum Pathol"},{"key":"R20-15-20210227","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.","volume":"25","author":"Horny","year":"2001","journal-title":"Leuk Res"},{"key":"R21-15-20210227","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000048180","article-title":"Histopathological and immunohistochemical aspects of mastocytosis.","volume":"127","author":"Horny","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"R22-15-20210227","first-page":"982","article-title":"Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.","volume":"9","author":"Li","year":"1996","journal-title":"Mod Pathol"},{"key":"R23-15-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12519-010-0205-0","article-title":"Langerhans cell histiocytosis of bone in children: a clinicopathologic study of 108 cases.","volume":"6","author":"Wang","year":"2010","journal-title":"World J Pediatr"},{"key":"R24-15-20210227","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.21561","article-title":"Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine.","volume":"84","author":"Lim","year":"2009","journal-title":"Am J Hematol"},{"key":"R25-15-20210227","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis.","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"key":"R26-15-20210227","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10428190400010775","article-title":"Matocytosis: pathology, genetics, and current options for therapy.","volume":"46","author":"Valent","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"R27-15-20210227","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1365-2222.2009.03353.x","article-title":"Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells.","volume":"39","author":"Krauth","year":"2009","journal-title":"Clin Exp Allergy"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e318279e392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:14:01Z","timestamp":1620965641000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201305000-00015"}},"subtitle":["A Case Report and Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e318279e392","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}